Quest Diagnostics (DGX) FY2022 results: revenue $9.9 billion, down 8.4% on the year
Quest Diagnostics Inc. (DGX) reported revenue of $9.9 billion for fiscal 2022, the year ended 31 December 2022, down 8.4% on the year before. Net income was $946 million, down 52.6%, and diluted earnings per share $7.97. The figures are the company's own, from the 10-K it filed with the SEC on 21 February 2023.
Revenue
$9.9 billion
-8.4% on the year
FY2015FY2022
Operating margin
14.4%
22.1% a year earlier
FY2015FY2022
Net income
$946 million
-52.6% on the year
FY2015FY2022
Diluted EPS
$7.97
-48.7% on the year
FY2015FY2022
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Operating cash flow
1,718
2,233
2,005
-23.1%
Capital expenditure
404
403
418
+0.2%
Free cash flow
1,314
1,830
1,587
-28.2%
Free cash flow margin
13.3%
17.0%
16.8%
Cash from investing
-543
21.0
-772
Cash from financing
-1,732
-2,540
-1,267
Depreciation and amortisation
437
408
361
+7.1%
Share-based compensation
77.0
79.0
97.0
-2.5%
Buybacks
1,408
2,199
325
-36.0%
Dividends paid
305
309
297
-1.3%
Diluted shares, weighted
118m
128m
136m
-7.8%
Balance sheet
$ million
FY2022
FY2021
FY2020
On the year
Last 8 years
Shareholders' equity
5,893
6,444
6,759
-8.6%
Non-controlling interest
37.0
39.0
50.0
-5.1%
Redeemable equity
77.0
79.0
82.0
-2.5%
Debt
3,980
4,012
4,015
-0.8%
Operating lease liabilities
489
494
499
-1.0%
Finance lease liabilities
7.0
32.0
25.0
-78.1%
Other liabilities
2,354
2,511
2,596
-6.3%
Total liabilities and equity
12,837
13,611
14,026
-5.7%
Fixed assets
1,766
1,707
1,627
+3.5%
Goodwill
7,220
7,095
6,873
+1.8%
Intangible assets
1,092
1,167
1,167
-6.4%
Securities held for sale or to maturity
2.0
1.0
12.0
+100.0%
Cash and equivalents
315
872
1,158
-63.9%
Receivables
1,195
1,438
1,520
-16.9%
Inventory
192
208
223
-7.7%
Other assets
1,055
1,123
1,446
-6.1%
Total assets
12,837
13,611
14,026
-5.7%
10-K for the year ended 31 December 2022, filed 21 February 2023: the filing.